Literature DB >> 26233617

High serum cancer antigen 125 level indicates perforation in acute appendicitis.

Erdinç Çetinkaya1, Ahmet Erdoğan2, Özgür Akgül2, Canbert Çelik2, Mesut Tez2.   

Abstract

BACKGROUND: The diagnosis of acute appendicitis is sometimes challenging, and prompt evaluation is required because of the risk of complications if not treated appropriately. AIM: We aimed to evaluate whether cancer antigen 125 (CA-125) has diagnositic accuracy and predictor of the severity in acute appendicitis.
RESULTS: Sixty patients with acute appendicitis were recruited prospectively in this study between May 2014 and March 2015. Blood samples were obtained to measure CA-125 levels before appendectomy. Of the 57 patients, 10 had perforated or gangrenous appendicitis intraoperatively. The CA-125 levels were significantly higher in patients with perforated or gangrenous appendicitis than patients with uncomplicated appendicitis (49.9 vs 10.5 U/mL, P=.000).
CONCLUSIONS: Cancer antigen 125 levels in patients with highly suspected or confirmed appendicitis could help clinicians determine the severity of the disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26233617     DOI: 10.1016/j.ajem.2015.07.001

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

Review 1.  Pediatric appendicitis: state of the art review.

Authors:  Rebecca M Rentea; Shawn D St Peter; Charles L Snyder
Journal:  Pediatr Surg Int       Date:  2016-10-14       Impact factor: 1.827

2.  Preoperative assessment of complicated appendicitis through stress reaction and clinical manifestations.

Authors:  Chun-Bo Kang; Wen-Qiang Li; Jian-Wei Zheng; Xiao-Wei Li; Da-Peng Lin; Xiu-Feng Chen; De-Zhong Wang; Nan Yao; Xue-Kai Liu; Jun Qu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Value of CA-125 Glycoprotein in Predicting Acute Appendicitis; a Diagnostic Accuracy Study.

Authors:  Mahboub Pouraghaei; Kavous Shahsavarinia; Farzad Kakaei; Sevda Gholipour-Khalili; Babak Mohammadpour; Payman Moharamzadeh; Moloud Balafar
Journal:  Arch Acad Emerg Med       Date:  2019-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.